CLINICAL ASSESSMENT OF RHEUMATOID ARTHRITIS*

CDAI, Clinical Disease Activity Index; CT, Computed Tomography; ESR, Erythrocyte Sedimentation Rate; PET, Positron Emission Tomography; CRP, C-Reactive Protein; SDAI, Simplified Disease Activity Index; DAS28, Disease Activity Score 28; MRI, Magnetic Resonance Imaging

This presentation is an exploration of current measures of disease progression in rheumatoid arthritis.

The program:

  • Describes components of common clinical assessments
  • Analyzes the advantages and limitations of the different measures
  • Outlines potential assessments appropriate for different clinical situations

This program is intended to be supplementary and should not by itself be considered complete training for clinical assessment.

Content developed in conjunction with Mark Genovese, MD.

*This program is for rheumatology fellows only.

Faculty

HOWARD M. BUSCH, DO, FACR

Diplomat
American Board of Internal Medicine
Diplomat
American Board of Rheumatology

Dr Busch received his Bachelor of Science degree from Hobart and William Smith Colleges in New York and completed his medical studies at the New York College of Osteopathic Medicine at the New York Institute of Technology.

Dr Busch completed his internship at Metropolitan Hospital in Philadelphia, followed by a medical residency at Norwalk Hospital (an affiliate of Yale University). During that residency, Dr Busch was appointed Chief Medical Resident and served as an instructor at Yale.

While completing his rheumatology fellowship at the University of Medicine and Dentistry, Dr Busch was awarded the Northeast Regional Fellow Award for Research.

The founder in 1987 of the Family Arthritis Center in Palm Beach County, FL, Dr Busch is the author of many scholarly articles, a noted national speaker, and an independent investigator for clinical trials.

SIMON MARC HELFGOTT, MD, CM

Director of Education & Fellowship Training
Brigham and Women’s Hospital
Division of Rheumatology
Associate Professor of Medicine
Harvard Medical School

Dr Helfgott is a graduate of McGill University Faculty of Medicine. He completed his fellowship training at Harvard Medical School and Brigham and Women’s Hospital and has remained an active member of the faculty.

Dr Helfgott’s interests include the clinical management of autoimmune inflammatory diseases, medical education and medical writing. He maintains an active consultation practice focused on the management of difficult-to-treat autoimmune and inflammatory disorders. He has helped establish several interdisciplinary clinics that provide expert consultation to patients with multisystem illnesses.

Since 2004, he has served as Director of Education & Fellowship Training in the Division of Rheumatology at Brigham and Women’s Hospital, one of the largest training programs in North America. His efforts have been recognized with his selection as the American College of Rheumatology 2017 Distinguished Program Director Award winner.

From 2012-2017, he has served as physician editor of The Rheumatologist, an official publication of the American College of Rheumatology that has become the most widely read periodical in rheumatology.

PHILIP J. MEASE, MD

Clinical Professor of Medicine
University of Washington School of Medicine
Director
Rheumatology Clinical Research Division,
Swedish Medical Center

Dr Mease is clinical professor of medicine at the University of Washington School of Medicine and director of the rheumatology clinical research division at Swedish Medical Center in Seattle, Washington.

Dr Mease received his undergraduate and medical degrees from Stanford University in Stanford, California. He completed his residency in internal medicine and fellowship in rheumatology at the University of Washington. He is a leading researcher and educator on disease state and treatment of rheumatic disorders.

His research focuses on emerging therapeutics and outcome measures for clinical trials. He has served as principal or coprincipal investigator on numerous clinical trials, including recent studies on therapies for psoriatic arthritis, ankylosing spondylitis, rheumatoid arthritis, fibromyalgia, and lupus, and has authored over 300 articles, numerous abstracts, and book chapters on these and related subjects.